"Immunotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
Below are MeSH descriptors whose meaning is more general than "Immunotherapy".
Below are MeSH descriptors whose meaning is more specific than "Immunotherapy".
This graph shows the total number of publications written about "Immunotherapy" by people in Harvard Catalyst Profiles by year, and whether "Immunotherapy" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 9 | 10 |
| 1994 | 3 | 6 | 9 |
| 1995 | 6 | 9 | 15 |
| 1996 | 7 | 4 | 11 |
| 1997 | 3 | 12 | 15 |
| 1998 | 2 | 3 | 5 |
| 1999 | 9 | 8 | 17 |
| 2000 | 11 | 6 | 17 |
| 2001 | 5 | 16 | 21 |
| 2002 | 13 | 15 | 28 |
| 2003 | 17 | 13 | 30 |
| 2004 | 15 | 15 | 30 |
| 2005 | 16 | 19 | 35 |
| 2006 | 9 | 14 | 23 |
| 2007 | 20 | 14 | 34 |
| 2008 | 20 | 23 | 43 |
| 2009 | 19 | 19 | 38 |
| 2010 | 25 | 16 | 41 |
| 2011 | 29 | 16 | 45 |
| 2012 | 22 | 33 | 55 |
| 2013 | 41 | 32 | 73 |
| 2014 | 42 | 30 | 72 |
| 2015 | 65 | 45 | 110 |
| 2016 | 80 | 54 | 134 |
| 2017 | 111 | 57 | 168 |
| 2018 | 132 | 101 | 233 |
| 2019 | 114 | 93 | 207 |
| 2020 | 113 | 119 | 232 |
| 2021 | 101 | 148 | 249 |
| 2022 | 34 | 184 | 218 |
| 2023 | 3 | 33 | 36 |
Below are the most recent publications written about "Immunotherapy" by people in Profiles.
-
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma. BMC Cancer. 2023 Mar 23; 23(1):265.
-
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nat Med. 2023 Mar; 29(3):632-645.
-
Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility. J Transl Med. 2023 Mar 15; 21(1):197.
-
Learnings about Aß from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer's disease immunotherapeutics. Acta Neuropathol Commun. 2023 03 10; 11(1):39.
-
Oncolytic virus therapy for malignant gliomas: entering the new era. Expert Opin Biol Ther. 2023 03; 23(3):269-282.
-
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors. J Immunother Cancer. 2023 Mar; 11(3).
-
Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha. Cancer Discov. 2023 03 01; 13(3):672-701.
-
Immune therapies in the treatment of multiple myeloma. Am J Hematol. 2023 Mar; 98 Suppl 2:S3.
-
Adoption of Innovative Therapies Across Oncology Practices-Evidence From Immunotherapy. JAMA Oncol. 2023 03 01; 9(3):324-333.
-
Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop. Lancet Oncol. 2023 03; 24(3):e133-e143.